CoChat
Sign Up
Cited by 23Pluripotent Stem Cells ResearchCRISPR and Genetic EngineeringMesenchymal stem cell research

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

An overview of reprogramming approaches to derive integration-free induced pluripotent stem cells for prospective biomedical applications

Dey, Chandrima, Raina, Khyati, Haridhasapavalan, Krishna Kumar, Thool, Madhuri, Sundaravadivelu, Pradeep Kumar, Adhikari, Poulomi, Gogoi, Ranadeep, Thummer, Rajkumar P.·2021·Recent Advances in iPSC Technology
DOI 10.1016/b978-0-12-822231-7.00011-4
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/b978-0-12-822231-7.00011-4

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Adenovirus and Sendai virus-mediated vector delivery provide alternative non-integrative methods for iPSC reprogramming.

    “Adenovirus and Sendai virus-mediated vector delivery provide alternative non-integrative methods for iPSC reprogramming [24,25,26,27,28].”

    From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [25]

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 211

  1. Ahuja, 2005, SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation, Oncogene, 24, 7729, 10.1038/sj.onc.1209046 · DOI
  2. Angel, 2010, Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins, PLoS One, 5, 10.1371/journal.pone.0011756 · DOI
  3. Anokye-Danso, 2011, Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency, Cell Stem Cell, 8, 376, 10.1016/j.stem.2011.03.001 · DOI
  4. Arnold, 2011, Reprogramming of human huntington fibroblasts using mRNA, ISRN Cell Biol., 2012
  5. Ban, 2011, Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors, Proc. Natl. Acad. Sci. U.S.A., 108, 14234, 10.1073/pnas.1103509108 · DOI
  6. Bang, 2018, Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblasts, Anim. Cell Syst., 22, 132, 10.1080/19768354.2018.1451367 · DOI
  7. Bayart, 2013, Technological overview of iPS induction from human adult somatic cells, Curr. Gene Ther., 13, 73, 10.2174/1566523211313020002 · DOI
  8. Beers, 2015, A cost-effective and efficient reprogramming platform for large-scale production of integration-free human induced pluripotent stem cells in chemically defined culture, Sci. Rep., 5, 11319, 10.1038/srep11319 · DOI
  9. Bitzer, 2003, Sendai virus vectors as an emerging negative‐strand RNA viral vector system, J. Gene Med., 5, 543, 10.1002/jgm.426 · DOI
  10. Borgohain, 2019, An insight into DNA-free reprogramming approaches to generate integration-free induced pluripotent stem cells for prospective biomedical applications, Stem Cell Rev. Rep., 15, 286, 10.1007/s12015-018-9861-6 · DOI
  11. Borgohain, 2018, Maximizing expression and yield of human recombinant proteins from bacterial cell factories for biomedical applications, Adv. Microb. Biotechnol., 447
  12. Bracken, 2008, A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition, Cancer Res., 68, 7846, 10.1158/0008-5472.CAN-08-1942 · DOI
  13. Cao, 2015, miR‐290/371‐Mbd2‐Myc circuit regulates glycolytic metabolism to promote pluripotency, EMBO J., 34, 609, 10.15252/embj.201490441 · DOI
  14. Card, 2008, Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells, Mol. Cell Biol., 28, 6426, 10.1128/MCB.00359-08 · DOI
  15. Castro, 2018, Generation of a human iPSC line by mRNA reprogramming, Stem Cell Res., 28, 157, 10.1016/j.scr.2018.02.011 · DOI
  16. Cha, 2017, Metabolic control of primed human pluripotent stem cell fate and function by the miR-200c–SIRT2 axis, Nat. Cell Biol., 19, 445, 10.1038/ncb3517 · DOI
  17. Chang, 2010, MicroRNA-induced pluripotent stem cells, Cell Stem Cell, 7, 31
  18. Chateauvieux, 2010, Molecular and therapeutic potential and toxicity of valproic acid, BioMed Res. Int., 2010
  19. Cheloufi, 2015, The histone chaperone CAF-1 safeguards somatic cell identity, Nature, 528, 218, 10.1038/nature15749 · DOI
  20. Chen, 2012, Synergetic cooperation of microRNAs with transcription factors in iPS cell generation, PLoS One, 7
  21. Cheng, 2012, Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression, Cell Stem Cell, 10, 337, 10.1016/j.stem.2012.01.005 · DOI
  22. Cho, 2010, Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation, Blood, 116, 386, 10.1182/blood-2010-02-269589 · DOI · Paper page
  23. Choi, 2016, Efficient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells, J. Contr. Release, 235, 222, 10.1016/j.jconrel.2016.06.007 · DOI
  24. Chou, 2015, A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder‐free and xeno‐free culture conditions: a clinically compliant approach, Stem Cells Transl. Med., 4, 320, 10.5966/sctm.2014-0214 · DOI
  25. Chou, 2011, Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures, Cell Res., 21, 518, 10.1038/cr.2011.12 · DOI
  26. Chung, 2010, Vitamin C promotes widespread yet specific DNA demethylation of the epigenome in human embryonic stem cells, Stem Cells, 28, 1848, 10.1002/stem.493 · DOI
  27. Desponts, 2010, Using small molecules to improve generation of induced pluripotent stem cells from somatic cells, Cell. Prog. Reprog., 207
  28. Dey, 2016, Thummer. Cell-penetrating peptides as a tool to deliver biologically active recombinant proteins to generate transgene-free induced pluripotent stem cells, Stud. Stem Cells Res. Ther., 3, 006, 10.17352/sscrt.000011 · DOI
  29. Dowey, 2012, Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression, Nat. Protoc., 7, 2013, 10.1038/nprot.2012.121 · DOI
  30. Drews, 2012, The cytotoxic and immunogenic hurdles associated with non-viral mRNA-mediated reprogramming of human fibroblasts, Biomaterials, 33, 4059, 10.1016/j.biomaterials.2012.02.025 · DOI
  31. Durruthy-Durruthy, 2014, Rapid and efficient conversion of integration-free human induced pluripotent stem cells to GMP-grade culture conditions, PLoS One, 9, 10.1371/journal.pone.0094231 · DOI
  32. Durruthy, 2014, Derivation of GMP-compliant integration-free hiPSCs using modified mRNAs, Stem Cells Good Manuf. Pract., 31
  33. Efe, 2011, The evolving biology of small molecules: controlling cell fate and identity, Phil. Trans. Biol. Sci., 366, 2208, 10.1098/rstb.2011.0006 · DOI
  34. El-Sayed, 2014, Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors, Int. J. Mol. Sci., 15, 21840, 10.3390/ijms151221840 · DOI
  35. Esteban, 2010, Vitamin C enhances the generation of mouse and human induced pluripotent stem cells, Cell Stem Cell, 6, 71, 10.1016/j.stem.2009.12.001 · DOI · Paper page
  36. Feldman, 2006, G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis, Nat. Cell Biol., 8, 188, 10.1038/ncb1353 · DOI · Paper page
  37. Feng, 2009, Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells, Cell Stem Cell, 4, 301, 10.1016/j.stem.2009.03.005 · DOI
  38. Foja, 2013, Hypoxia supports reprogramming of mesenchymal stromal cells via induction of embryonic stem cell–specific microRNA-302 cluster and pluripotency-associated genes, Cell. Reprogr., 15, 68, 10.1089/cell.2012.0037 · DOI
  39. Folmes, 2013, Metabolome and metaboproteome remodeling in nuclear reprogramming, Cell Cycle, 12, 2355, 10.4161/cc.25509 · DOI
  40. Folmes, 2011, Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming, Cell Metab., 14, 264, 10.1016/j.cmet.2011.06.011 · DOI
  41. Fuhrhop, 2004, Bolaamphiphiles, Chem. Rev., 104, 2901, 10.1021/cr030602b · DOI
  42. Fujie, 2014, New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood, PLoS One, 9, 10.1371/journal.pone.0113052 · DOI
  43. Fusaki, 2009, Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome, Proc. Jpn. Acad. Ser. B, 85, 348, 10.2183/pjab.85.348 · DOI · Paper page
  44. Gao, 2015, Vitamin C induces a pluripotent state in mouse embryonic stem cells by modulating micro RNA expression, FEBS J., 282, 685, 10.1111/febs.13173 · DOI
  45. Goh, 2013, A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific induced pluripotent stem (iPS) cells, PLoS One, 8, 10.1371/journal.pone.0081622 · DOI
  46. Gómez-Aguado, 2020, Nanomedicines to deliver mRNA: state of the art and future perspectives, Nanomaterials, 10, 364, 10.3390/nano10020364 · DOI
  47. González, 2011, Methods for making induced pluripotent stem cells: reprogramming a la carte, Nat. Rev. Genet., 12, 231, 10.1038/nrg2937 · DOI
  48. Gregory, 2008, The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1, Nat. Cell Biol., 10, 593, 10.1038/ncb1722 · DOI
  49. Guo, 2013, microRNA-29b is a novel mediator of Sox2 function in the regulation of somatic cell reprogramming, Cell Res., 23, 142, 10.1038/cr.2012.180 · DOI
  50. Haase, 2017, Generation of non-transgenic iPS cells from human cord blood CD34+ cells under animal component-free conditions, Stem Cell Res., 21, 71, 10.1016/j.scr.2017.03.022 · DOI
  51. Hanna, 2009, Direct cell reprogramming is a stochastic process amenable to acceleration, Nature, 462, 595, 10.1038/nature08592 · DOI · Paper page
  52. Haridhasapavalan, 2019, An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells, Gene, 686, 146, 10.1016/j.gene.2018.11.069 · DOI
  53. Haridhasapavalan, 2020, An insight into reprogramming barriers to iPSC generation, Stem Cell Rev. Rep., 16, 56, 10.1007/s12015-019-09931-1 · DOI
  54. He, 2014, Human fibroblast reprogramming to pluripotent stem cells regulated by the miR19a/b-PTEN axis, PLoS One, 9
  55. Heng, 2013, mRNA transfection-based, feeder-free, induced pluripotent stem cells derived from adipose tissue of a 50-year-old patient, Metab. Eng., 18, 9, 10.1016/j.ymben.2013.02.004 · DOI
  56. Hosoya, 2008, Comparison between Sendai virus and adenovirus vectors to transduce HIV‐1 genes into human dendritic cells, J. Med. Virol., 80, 373, 10.1002/jmv.21052 · DOI
  57. Hou, 2013, Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds, Science, 341, 651, 10.1126/science.1239278 · DOI · Paper page
  58. Hu, 2014, All roads lead to induced pluripotent stem cells: the technologies of iPSC generation, Stem Cells Dev., 23, 1285, 10.1089/scd.2013.0620 · DOI · Paper page
  59. Hu, 2011, Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells, Blood, 117, e109, 10.1182/blood-2010-07-298331 · DOI
  60. Hu, 2013, MicroRNA‐302 increases reprogramming efficiency via repression of NR2F2, Stem Cells, 31, 259, 10.1002/stem.1278 · DOI
  61. Hu, 2014, Tet and TDG mediate DNA demethylation essential for mesenchymal-to-epithelial transition in somatic cell reprogramming, Cell Stem Cell, 14, 512, 10.1016/j.stem.2014.01.001 · DOI
  62. Huangfu, 2008, Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds, Nat. Biotechnol., 26, 795, 10.1038/nbt1418 · DOI
  63. Huangfu, 2008, Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2, Nat. Biotechnol., 26, 1269, 10.1038/nbt.1502 · DOI
  64. Ichida, 2009, A small-molecule inhibitor of Tgf-β signaling replaces Sox2 in reprogramming by inducing Nanog, Cell Stem Cell, 5, 491, 10.1016/j.stem.2009.09.012 · DOI · Paper page
  65. Inoue, 2003, A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading, J. Virol., 77, 6419, 10.1128/JVI.77.11.6419-6429.2003 · DOI
  66. Inoue, 2003, Nontransmissible virus-like particle formation by F-deficient Sendai virus is temperature sensitive and reduced by mutations in M and HN proteins, J. Virol., 77, 3238, 10.1128/JVI.77.5.3238-3246.2003 · DOI
  67. Jackson-Grusby, 1997, Mutagenicity of 5-aza-2′-deoxycytidine is mediated by the mammalian DNA methyltransferase, Proc. Natl. Acad. Sci. U.S.A., 94, 4681, 10.1073/pnas.94.9.4681 · DOI
  68. Jiang, 2014, Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy, Stem Cells Dev., 23, 2613, 10.1089/scd.2014.0110 · DOI
  69. Jin, 2015, Transfection of microRNA mimics should be used with caution, Front. Genet., 6, 340, 10.3389/fgene.2015.00340 · DOI
  70. Judson, 2009, Embryonic stem cell–specific microRNAs promote induced pluripotency, Nat. Biotechnol., 27, 459, 10.1038/nbt.1535 · DOI
  71. Judson, 2013, MicroRNA-based discovery of barriers to dedifferentiation of fibroblasts to pluripotent stem cells, Nat. Struct. Mol. Biol., 20, 1227, 10.1038/nsmb.2665 · DOI
  72. Kadari, 2014, Excision of viral reprogramming cassettes by Cre protein transduction enables rapid, robust and efficient derivation of transgene-free human induced pluripotent stem cells, Stem Cell Res. Ther., 5, 47, 10.1186/scrt435 · DOI
  73. Kaitsuka, 2015, Cell-penetrating peptide as a means of directing the differentiation of induced-pluripotent stem cells, Int. J. Mol. Sci., 16, 26667, 10.3390/ijms161125986 · DOI
  74. Kaji, 2009, Virus-free induction of pluripotency and subsequent excision of reprogramming factors, Nature, 458, 771, 10.1038/nature07864 · DOI
  75. Kang, 2014, Reprogramming of mouse somatic cells into pluripotent stem-like cells using a combination of small molecules, Biomaterials, 35, 7336, 10.1016/j.biomaterials.2014.05.015 · DOI
  76. Kang, 2015, Effects of integrating and non-integrating reprogramming methods on copy number variation and genomic stability of human induced pluripotent stem cells, PLoS One, 10
  77. Kida, 2015, ERRs mediate a metabolic switch required for somatic cell reprogramming to pluripotency, Cell Stem Cell, 16, 547, 10.1016/j.stem.2015.03.001 · DOI
  78. Kim, 2012, MicroRNAs are indispensable for reprogramming mouse embryonic fibroblasts into induced stem cell-like cells, PLoS One, 7
  79. Kim, 2009, Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins, Cell Stem Cell, 4, 472, 10.1016/j.stem.2009.05.005 · DOI · Paper page
  80. Kogut, 2018, High-efficiency RNA-based reprogramming of human primary fibroblasts, Nat. Commun., 9, 1, 10.1038/s41467-018-03190-3 · DOI
  81. Kondoh, 2007, A high glycolytic flux supports the proliferative potential of murine embryonic stem cells, Antioxid. Redox Signal., 9, 293, 10.1089/ars.2006.1467 · DOI · Paper page
  82. Konno, 2015, Embryonic microRNA-369 controls metabolic splicing factors and urges cellular reprograming, PLoS One, 10, 10.1371/journal.pone.0132789 · DOI
  83. Konno, 2011, Intracellular reactivation of transcription factors fused with protein transduction domain, J. Biotechnol., 154, 298, 10.1016/j.jbiotec.2011.05.006 · DOI
  84. Korpal, 2008, The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2, J. Biol. Chem., 283, 14910, 10.1074/jbc.C800074200 · DOI
  85. Kowalski, 2019, Delivering the messenger: advances in technologies for therapeutic mRNA delivery, Mol. Ther., 27, 710, 10.1016/j.ymthe.2019.02.012 · DOI · Paper page
  86. Kumar, 2011, Negative regulation of the tumor suppressor p53 gene by microRNAs, Oncogene, 30, 843, 10.1038/onc.2010.457 · DOI
  87. Lachner, 2001, Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins, Nature, 410, 116, 10.1038/35065132 · DOI · Paper page
  88. Lai, 2010, ROCK inhibition facilitates the generation of human-induced pluripotent stem cells in a defined, feeder-, and serum-free system, Cell. Reprogr., 12, 641, 10.1089/cell.2010.0051 · DOI
  89. Lee, 2012, Activation of innate immunity is required for efficient nuclear reprogramming, Cell, 151, 547, 10.1016/j.cell.2012.09.034 · DOI
  90. Lee, 2016, Extracellular matrix-dependent generation of integration-and xeno-free iPS cells using a modified mRNA transfection method, Stem Cells Int., 2016, 10.1155/2016/6853081 · DOI
  91. Lee, 2016, MiR-31/SDHA axis regulates reprogramming efficiency through mitochondrial metabolism, Stem Cell Rep., 7, 1, 10.1016/j.stemcr.2016.05.012 · DOI
  92. Lee, 2013, Epigenetic regulation of Nanog by MiR‐302 cluster‐MBD2 completes induced pluripotent stem cell reprogramming, Stem Cells, 31, 666, 10.1002/stem.1302 · DOI
  93. Lee, 2016, Dissecting microRNA-mediated regulation of stemness, reprogramming, and pluripotency, Cell Regen., 5, 2, 10.1186/s13619-016-0028-0 · DOI
  94. Leonardo, 2012, The functions of microRNAs in pluripotency and reprogramming, Nat. Cell Biol., 14, 1114, 10.1038/ncb2613 · DOI
  95. Li, 2000, A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression, J. Virol., 74, 6564, 10.1128/JVI.74.14.6564-6569.2000 · DOI
  96. Li, 2010, A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts, Cell Stem Cell, 7, 51, 10.1016/j.stem.2010.04.014 · DOI · Paper page
  97. Li, 2012, Identification of Oct4-activating compounds that enhance reprogramming efficiency, Proc. Natl. Acad. Sci. U.S.A., 109, 20853, 10.1073/pnas.1219181110 · DOI
  98. Li, 2009, Generation of human‐induced pluripotent stem cells in the absence of exogenous Sox2, Stem Cells, 27, 2992, 10.1002/stem.240 · DOI
  99. Li, 2014, Generation of pluripotent stem cells via protein transduction, Int. J. Dev. Biol., 58, 21, 10.1387/ijdb.140007XL · DOI
  100. Li, 2011, Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules, Cell Res., 21, 196, 10.1038/cr.2010.142 · DOI
  101. Li, 2014, MicroRNA-mediated regulation of extracellular matrix formation modulates somatic cell reprogramming, RNA, 20, 1900, 10.1261/rna.043745.113 · DOI
  102. Li, 2012, A kinase inhibitor screen identifies small-molecule enhancers of reprogramming and iPS cell generation, Nat. Commun., 3, 1, 10.1038/ncomms2059 · DOI
  103. Li, 2011, Small RNA‐mediated regulation of iPS cell generation, EMBO J., 30, 823, 10.1038/emboj.2011.2 · DOI
  104. Liang, 2010, Butyrate promotes induced pluripotent stem cell generation, J. Biol. Chem., 285, 25516, 10.1074/jbc.M110.142059 · DOI
  105. Liao, 2011, MicroRNA cluster 302–367 enhances somatic cell reprogramming by accelerating a mesenchymal-to-epithelial transition, J. Biol. Chem., 286, 17359, 10.1074/jbc.C111.235960 · DOI
  106. Lin, 2008, Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state, RNA, 14, 2115, 10.1261/rna.1162708 · DOI
  107. Lin, 2011, Regulation of somatic cell reprogramming through inducible mir-302 expression, Nucleic Acids Res., 39, 1054, 10.1093/nar/gkq850 · DOI
  108. Lin, 2009, A chemical platform for improved induction of human iPSCs, Nat. Methods, 6, 805, 10.1038/nmeth.1393 · DOI
  109. Lluis, 2008, Periodic activation of Wnt/β-catenin signaling enhances somatic cell reprogramming mediated by cell fusion, Cell Stem Cell, 3, 493, 10.1016/j.stem.2008.08.017 · DOI
  110. Long, 2015, Bromodeoxyuridine promotes full-chemical induction of mouse pluripotent stem cells, Cell Res., 25, 1171, 10.1038/cr.2015.96 · DOI
  111. Lu, 2012, MiR-25 regulates Wwp2 and Fbxw7 and promotes reprogramming of mouse fibroblast cells to iPSCs, PLoS One, 7, 10.1371/journal.pone.0040938 · DOI
  112. Lu, 2014, Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells, Cell Stem Cell, 15, 92, 10.1016/j.stem.2014.04.002 · DOI
  113. Lyssiotis, 2009, Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4, Proc. Natl. Acad. Sci. U.S.A., 106, 8912, 10.1073/pnas.0903860106 · DOI
  114. MacArthur, 2012, Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions, Stem Cells Int., 2012, 10.1155/2012/564612 · DOI · Paper page
  115. Maherali, 2008, Guidelines and techniques for the generation of induced pluripotent stem cells, Cell Stem Cell, 3, 595, 10.1016/j.stem.2008.11.008 · DOI
  116. Maherali, 2009, Tgfβ signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc, Curr. Biol., 19, 1718, 10.1016/j.cub.2009.08.025 · DOI · Paper page
  117. Mali, 2010, Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency‐associated genes, Stem Cells, 28, 713, 10.1002/stem.402 · DOI · Paper page
  118. Mandal, 2013, Reprogramming human fibroblasts to pluripotency using modified mRNA, Nat. Protoc., 8, 568, 10.1038/nprot.2013.019 · DOI
  119. Marchion, 2005, Valproic acid alters chromatin structure by regulation of chromatin modulation proteins, Cancer Res., 65, 3815, 10.1158/0008-5472.CAN-04-2478 · DOI
  120. Marson, 2008, Wnt signaling promotes reprogramming of somatic cells to pluripotency, Cell Stem Cell, 3, 132, 10.1016/j.stem.2008.06.019 · DOI
  121. Meng, 2012, Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone, Mol. Ther., 20, 408, 10.1038/mt.2011.258 · DOI
  122. Menon, 2016, An overview of direct somatic reprogramming: the ins and outs of iPSCs, Int. J. Mol. Sci., 17, 141, 10.3390/ijms17010141 · DOI
  123. Mens, 2018, Cell cycle regulation of stem cells by MicroRNAs, Stem Cell Rev. Rep., 14, 309, 10.1007/s12015-018-9808-y · DOI
  124. Mikkelsen, 2008, Dissecting direct reprogramming through integrative genomic analysis, Nature, 454, 49, 10.1038/nature07056 · DOI
  125. Miyoshi, 2011, Reprogramming of mouse and human cells to pluripotency using mature microRNAs, Cell Stem Cell, 8, 633, 10.1016/j.stem.2011.05.001 · DOI
  126. Moon, 2011, Reprogramming fibroblasts into induced pluripotent stem cells with Bmi1, Cell Res., 21, 1305, 10.1038/cr.2011.107 · DOI
  127. Nakagawa, 2010, Promotion of direct reprogramming by transformation-deficient Myc, Proc. Natl. Acad. Sci. U.S.A., 107, 14152, 10.1073/pnas.1009374107 · DOI
  128. Nanbo, 2007, The coupling of synthesis and partitioning of EBV’s plasmid replicon is revealed in live cells, EMBO J., 26, 4252, 10.1038/sj.emboj.7601853 · DOI
  129. Nemes, 2014, Generation of mouse induced pluripotent stem cells by protein transduction, Tissue Eng. C Methods, 20, 383, 10.1089/ten.tec.2013.0026 · DOI
  130. Nguyen, 2017, miR-524-5p of the primate-specific C19MC miRNA cluster targets TP53IPN1-and EMT-associated genes to regulate cellular reprogramming, Stem Cell Res. Ther., 8, 214, 10.1186/s13287-017-0666-3 · DOI
  131. Nishimura, 2017, Simple and effective generation of transgene-free induced pluripotent stem cells using an auto-erasable Sendai virus vector responding to microRNA-302, Stem Cell Res., 23, 13, 10.1016/j.scr.2017.06.011 · DOI
  132. Nishimura, 2011, Development of defective and persistent Sendai virus vector a unique gene delivery/expression system ideal for cell reprogramming, J. Biol. Chem., 286, 4760, 10.1074/jbc.M110.183780 · DOI
  133. Okita, 2007, Generation of germline-competent induced pluripotent stem cells, Nature, 448, 313, 10.1038/nature05934 · DOI
  134. Okita, 2011, A more efficient method to generate integration-free human iPS cells, Nat. Methods, 8, 409, 10.1038/nmeth.1591 · DOI · Paper page
  135. Okita, 2013, An efficient nonviral method to generate integration‐free human‐induced pluripotent stem cells from cord blood and peripheral blood cells, Stem Cells, 31, 458, 10.1002/stem.1293 · DOI
  136. Onder, 2012, Chromatin-modifying enzymes as modulators of reprogramming, Nature, 483, 598, 10.1038/nature10953 · DOI
  137. Ono, 2012, Generation of induced pluripotent stem cells from human nasal epithelial cells using a Sendai virus vector, PLoS One, 7, 10.1371/journal.pone.0042855 · DOI
  138. Panopoulos, 2012, The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming, Cell Res., 22, 168, 10.1038/cr.2011.177 · DOI
  139. Pasha, 2011, Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells, PLoS One, 6, 10.1371/journal.pone.0023667 · DOI
  140. Peterson, 1981, 5-Azacytidine and renal tubular dysfunction, Blood, 10.1182/blood.V57.1.182.182 · DOI
  141. Pfaff, 2011, miRNA screening reveals a new miRNA family stimulating iPS cell generation via regulation of Meox2, EMBO Rep., 12, 1153, 10.1038/embor.2011.176 · DOI
  142. Plews, 2010, Activation of pluripotency genes in human fibroblast cells by a novel mRNA based approach, PLoS One, 5, 10.1371/journal.pone.0014397 · DOI
  143. Poleganov, 2015, Efficient reprogramming of human fibroblasts and blood-derived endothelial progenitor cells using nonmodified RNA for reprogramming and immune evasion, Hum. Gene Ther., 26, 751, 10.1089/hum.2015.045 · DOI · Paper page
  144. Preskey, 2016, Synthetically modified mRNA for efficient and fast human iPS cell generation and direct transdifferentiation to myoblasts, Biochem. Biophys. Res. Commun., 473, 743, 10.1016/j.bbrc.2015.09.102 · DOI
  145. Prigione, 2010, The senescence‐related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells, Stem Cells, 28, 721, 10.1002/stem.404 · DOI
  146. Ramos-Mejía, 2012, Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors, PLoS One, 7, 10.1371/journal.pone.0035824 · DOI
  147. Rao, 2012, Assessing iPSC reprogramming methods for their suitability in translational medicine, J. Cell. Biochem., 113, 3061, 10.1002/jcb.24183 · DOI
  148. Rohani, 2016, Generation of human induced pluripotent stem cells using non-synthetic mRNA, Stem Cell Res., 16, 662, 10.1016/j.scr.2016.03.008 · DOI
  149. Ruiz, 2011, A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity, Curr. Biol., 21, 45, 10.1016/j.cub.2010.11.049 · DOI
  150. Ryu, 2016, Soluble expression and stability enhancement of transcription factors using 30Kc19 cell-penetrating protein, Appl. Microbiol. Biotechnol., 100, 3523, 10.1007/s00253-015-7199-4 · DOI
  151. Saha, 2018, iPS cell generation: current and future challenges, Ann. Stem Cell Res. Ther., 1, 1007
  152. Samavarchi-Tehrani, 2010, Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming, Cell Stem Cell, 7, 64, 10.1016/j.stem.2010.04.015 · DOI · Paper page
  153. Schlaeger, 2015, A comparison of non-integrating reprogramming methods, Nat. Biotechnol., 33, 58, 10.1038/nbt.3070 · DOI
  154. Schmitt, 2017, Fluorescent tagged episomals for stoichiometric induced pluripotent stem cell reprogramming, Stem Cell Res. Ther., 8, 132, 10.1186/s13287-017-0581-7 · DOI
  155. Seki, 2010, Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells, Cell Stem Cell, 7, 11, 10.1016/j.stem.2010.06.003 · DOI · Paper page
  156. Seo, 2017, Cellular reprogramming using protein and cell-penetrating peptides, Int. J. Mol. Sci., 18, 552, 10.3390/ijms18030552 · DOI
  157. Sherstyuk, 2019, A new MicroRNA cluster involved in the reprogramming to a pluripotent state, Acta Nat. (англоязычная версия), 11
  158. Shi, 2008, Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds, Cell Stem Cell, 3, 568, 10.1016/j.stem.2008.10.004 · DOI
  159. Shi, 2008, A combined chemical and genetic approach for the generation of induced pluripotent stem cells, Cell Stem Cell, 2, 525, 10.1016/j.stem.2008.05.011 · DOI
  160. Silva, 2008, Promotion of reprogramming to ground state pluripotency by signal inhibition, PLoS Biol., 6, 10.1371/journal.pbio.0060253 · DOI
  161. Singh, 2015, Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery, Front. Cell Dev. Biol., 3, 2, 10.3389/fcell.2015.00002 · DOI
  162. Søkilde, 2015, Passenger strand loading in overexpression experiments using microRNA mimics, RNA Biol., 12, 787, 10.1080/15476286.2015.1020270 · DOI
  163. Somers, 2010, Generation of transgene‐free lung disease‐specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette, Stem Cells, 28, 1728, 10.1002/stem.495 · DOI · Paper page
  164. Stadtfeld, 2012, Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all–iPS cell mice from terminally differentiated B cells, Nat. Genet., 44, 398, 10.1038/ng.1110 · DOI · Paper page
  165. Staerk, 2011, Pan‐Src family kinase inhibitors replace Sox2 during the direct reprogramming of somatic cells, Angew. Chem. Int. Ed., 50, 5734, 10.1002/anie.201101042 · DOI
  166. Steichen, 2014, Messenger RNA‐versus retrovirus‐based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrity, Stem Cells Transl. Med., 3, 686, 10.5966/sctm.2013-0158 · DOI
  167. Su, 2013, Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors, PLoS One, 8
  168. Subramanyam, 2011, Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells, Nat. Biotechnol., 29, 443, 10.1038/nbt.1862 · DOI
  169. Suh, 2004, Human embryonic stem cells express a unique set of microRNAs, Dev. Biol., 270, 488, 10.1016/j.ydbio.2004.02.019 · DOI
  170. Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
  171. Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
  172. Takashina, 2018, Identification of a cell-penetrating peptide applicable to a protein-based transcription activator-like effector expression system for cell engineering, Biomaterials, 173, 11, 10.1016/j.biomaterials.2018.04.040 · DOI
  173. Tan, 2014, Human finger‐prick induced pluripotent stem cells facilitate the development of stem cell banking, Stem Cells Transl. Med., 3, 586, 10.5966/sctm.2013-0195 · DOI
  174. Tan, 2018, Efficient generation of transgene-and feeder-free induced pluripotent stem cells from human dental mesenchymal stem cells and their chemically defined differentiation into cardiomyocytes, Biochem. Biophys. Res. Commun., 495, 2490, 10.1016/j.bbrc.2017.12.007 · DOI
  175. Tavernier, 2012, Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc, Biomaterials, 33, 412, 10.1016/j.biomaterials.2011.09.062 · DOI
  176. Thier, 2010, Exploring refined conditions for reprograming cells by recombinant Oct4 protein, Int. J. Dev. Biol., 54, 1713, 10.1387/ijdb.103193mt · DOI
  177. Thier, 2012, Cellular reprogramming employing recombinant sox2 protein, Stem Cells Int., 2012, 10.1155/2012/549846 · DOI
  178. Trokovic, 2013, Small molecule inhibitors promote efficient generation of induced pluripotent stem cells from human skeletal myoblasts, Stem Cells Dev., 22, 114, 10.1089/scd.2012.0157 · DOI
  179. Trokovic, 2014, Advanced feeder‐free generation of induced pluripotent stem cells directly from blood cells, Stem Cells Transl. Med., 3, 1402, 10.5966/sctm.2014-0113 · DOI
  180. Tucker, 2013, Use of a synthetic xeno‐free culture substrate for induced pluripotent stem cell induction and retinal differentiation, Stem Cells Transl. Med., 2, 16, 10.5966/sctm.2012-0040 · DOI
  181. Van Craenenbroeck, 2000, Episomal vectors for gene expression in mammalian cells, Eur. J. Biochem., 267, 5665, 10.1046/j.1432-1327.2000.01645.x · DOI · Paper page
  182. Varum, 2011, Energy metabolism in human pluripotent stem cells and their differentiated counterparts, PLoS One, 6, 10.1371/journal.pone.0020914 · DOI · Paper page
  183. Walev, 2001, Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O, Proc. Natl. Acad. Sci. U.S.A., 98, 3185, 10.1073/pnas.051429498 · DOI · Paper page
  184. Wang, 2013, Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation, Proc. Natl. Acad. Sci. U.S.A., 110, 2858, 10.1073/pnas.1212769110 · DOI · Paper page
  185. Wang, 2011, Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells, Cell Res., 21, 1424, 10.1038/cr.2011.108 · DOI
  186. Warren, 2010, Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA, Cell Stem Cell, 7, 618, 10.1016/j.stem.2010.08.012 · DOI · Paper page
  187. Warren, 2013, Feeder‐free reprogramming of human fibroblasts with messenger RNA, Curr. Protoc. Stem Cell Biol., 27, 10.1002/9780470151808.sc04a06s27 · DOI
  188. Wen, 2016, Enhanced generation of integration-free iPSCs from human adult peripheral blood mononuclear cells with an optimal combination of episomal vectors, Stem Cell Rep., 6, 873, 10.1016/j.stemcr.2016.04.005 · DOI
  189. Wiley, 2016, cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness, Sci. Rep., 6, 1, 10.1038/srep30742 · DOI
  190. Wilson, 2009, MicroRNA profiling of human-induced pluripotent stem cells, Stem Cells Dev., 18, 749, 10.1089/scd.2008.0247 · DOI
  191. Wu, 2017, miR-6539 is a novel mediator of somatic cell reprogramming that represses the translation of Dnmt3b, J. Reprod. Dev., 63, 415, 10.1262/jrd.2016-170 · DOI
  192. Yakubov, 2010, Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors, Biochem. Biophys. Res. Commun., 394, 189, 10.1016/j.bbrc.2010.02.150 · DOI
  193. Ye, 2012, MiR‐138 promotes induced pluripotent stem cell generation through the regulation of the p53 signaling, Stem Cells, 30, 1645, 10.1002/stem.1149 · DOI
  194. Ye, 2018, Efficient generation of non-integration and feeder-free induced pluripotent stem cells from human peripheral blood cells by Sendai virus, Cell. Physiol. Biochem., 50, 1318, 10.1159/000494589 · DOI
  195. Ye, 2016, Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds, Cell Res., 26, 34, 10.1038/cr.2015.142 · DOI
  196. Yoshizaki, 2006, Naked Sendai virus vector lacking all of the envelope‐related genes: reduced cytopathogenicity and immunogenicity, J. Gene Med., 8, 1151, 10.1002/jgm.938 · DOI
  197. Young, 2012, Patient-specific induced pluripotent stem cells as a platform for disease modeling. Drug discovery and precision personalized medicine, J. Stem Cell Res. Ther., 10, 2
  198. Yu, 2009, Human induced pluripotent stem cells free of vector and transgene sequences, Science, 324, 797, 10.1126/science.1172482 · DOI · Paper page
  199. Yu, 2007, Induced pluripotent stem cell lines derived from human somatic cells, Science, 318, 1917, 10.1126/science.1151526 · DOI · Paper page
  200. Yuan, 2011, Brief report: combined chemical treatment enables Oct4‐induced reprogramming from mouse embryonic fibroblasts, Stem Cells, 29, 549, 10.1002/stem.594 · DOI

200 of 211 shown

Cited by

Sorted by citations

Metadata

Authors
Dey, C., Raina, K., Haridhasapavalan, K. K., Thool, M., Sundaravadivelu, P. K., Adhikari, P., Gogoi, R., & Thummer, R. P.
Affiliations
  • Indian Institute of Technology Guwahati (IN)
  • National Institute of Pharmaceutical Education and Research (IN)
ORCID
Venue
Recent Advances in iPSC Technology
Publisher
Elsevier
Published
2021
Pages
231-287
DOI
10.1016/b978-0-12-822231-7.00011-4
OpenAlex
W3146680789
Cited by
23
References
8
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 9 · 2022: 6 · 2021: 5
FWCI
8.86
Type
book chapter
Language
en
Open access
closed
Licence
Locations
Elsevier eBooks (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords
induced pluripotent stem cells, integration-free reprogramming, Sendai virus vector, episomal vectors, small molecule reprogramming, insertional mutagenesis, disease modeling, drug screening

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review